| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/05/2008 | US20080131509 Self-reinforcing composite biomatrix; use in tissue repair of myocardial infarct for example; two-component gelation system, and a silk protein such as silk-elastin, silk-collagen, silk-laminin, optionally conjugated to a biopolymer |
| 06/05/2008 | US20080131503 oral administration comprising a fixed dose combination of a first solid pharmaceutical composition containing fenofibrate as the active substance and second solid pharmaceutical composition containing an HMG-CoA reductase inhibitor such as a statin as the active substance, wherein the first dosage |
| 06/05/2008 | US20080131474 Promoting cardiac tissue repair while inhibiting or reducing vascular occlusion and/or restenosis |
| 06/05/2008 | US20080131464 Vaccines |
| 06/05/2008 | US20080131461 Using low neutralized recombinant adenoviral vectors harboring nucleic acids encoding circumsporozoite antigens from plasmodium falciparum and purified recombinant protein adjuvants; kits; dosage regimen |
| 06/05/2008 | US20080131452 Using primate hepadnavirus loop region polypeptide sequences as tool in developing vaccine to prevent and treat viral infection |
| 06/05/2008 | US20080131448 Using interleukin receptor as tool in treatment cell proliferative disorders; antitumor agents |
| 06/05/2008 | US20080131441 Methods of Using FOXP3 Levels to Predict the Outcome of Organs Undergoing Acute Rejection |
| 06/05/2008 | US20080131440 Using ultra-low doses of monoconal, polycloncal or natural antibodies to treat infectious disease |
| 06/05/2008 | US20080131438 Antibodies to non-functional p2x7 receptor |
| 06/05/2008 | US20080131432 Using inflixmab to decrease serum level of tumor necrosis factor, prevent p53 translocation to mitochondria and maintain mitochondrial respiration to nervous system tissues; side effect reduction and antitumor agents |
| 06/05/2008 | US20080131426 Using kallikren specific immunoglobulin as therapeutic tool in treating cardiocascular disorders; tissue repair |
| 06/05/2008 | US20080131422 Brain protein specific immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease |
| 06/05/2008 | US20080131421 Neisserial antigens |
| 06/05/2008 | US20080131414 Use of selected lactic acid bacteria for reducing infantile colic |
| 06/05/2008 | US20080131411 Using vector transformation comprising wildtype fkhsf gene as therapeutic in prevention and treatment of skin and kidney disorders |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | US20080131375 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis |
| 06/05/2008 | US20080131373 Fab proteins; anticancer agents; immunoglobulins; gene expression inhibition; kits |
| 06/05/2008 | US20080131370 For prophylaxis or treatment of apoptosis or inflammation-associated disease, diabetes, or chronic obstructive pulmonary disease |
| 06/05/2008 | DE60129697T2 Kondensierte azepinderivate und ihre verwendung als antidiuretisches mittel Condensed azepine derivatives and their use as antidiuretic agent |
| 06/05/2008 | CA2671080A1 Carboxylic acid derivatives |
| 06/05/2008 | CA2670984A1 Novel curcumin derivative |
| 06/05/2008 | CA2670123A1 Substituted quinazolines |
| 06/05/2008 | CA2670116A1 Methods of treating mental retardation, down's syndrome, fragile x syndrome and autism |
| 06/05/2008 | CA2668811A1 Methods of treating cognitive impairment and dementia |
| 06/05/2008 | CA2668713A1 Novel phenyl-isoxazol-3-ol derivative |
| 06/05/2008 | CA2664400A1 Particles for cell targeting |
| 06/04/2008 | EP1927367A1 Novel pharmaceutical using anti-hla antibody |
| 06/04/2008 | EP1927359A2 2-Methoxyestradiol for the treatment of inflammatory disorders |
| 06/04/2008 | EP1927349A1 Composition for life extension and method of extending the life |
| 06/04/2008 | EP1493033B1 Use of sc6 for diagnosis and treatment of breast carcinoma |
| 06/04/2008 | EP1487817B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 06/04/2008 | EP1456357B1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 06/04/2008 | EP1448089A4 Devices and methods for the restoration of a spinal disc |
| 06/04/2008 | EP1395591B1 Corticotropin releasing factor antagonists |
| 06/04/2008 | EP1392688B1 Pyrazino[1',2':1,6]-pyrido[3,4-b] indole-1,4-dione derivatives |
| 06/04/2008 | EP1365781B1 Acrochordon alleviation |
| 06/04/2008 | EP1343775B1 Piperazine derivatives |
| 06/04/2008 | EP1237887B1 9-(piperazinylalkyl)carbazoles as bax-modulators |
| 06/04/2008 | EP1193250B1 Phenyl sulfamate derivatives |
| 06/04/2008 | EP1019082B2 Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 06/04/2008 | EP0672143B1 Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof |
| 06/04/2008 | CN101193878A Agent for treatment of solid tumor |
| 06/04/2008 | CN101193877A Agent for treatment of hematopoietic tumor |
| 06/04/2008 | CN101190330A Application of cholinesterase in antagonistic tachykinin medicine |
| 06/04/2008 | CN101190295A Heat-clearing, detoxication and lag-dispelling Chinese herbal medicine health care cold tea and its preparation method |
| 06/04/2008 | CN101190291A í«Tianjingzhongzigaoí» (an externally-applied plaster) special for treating soreness and weakness of the loins and knees |
| 06/04/2008 | CN101190290A Medicine for treating appendicitis |
| 06/04/2008 | CN101190255A Kudzu root total flavone extracting after steam-explosion process |
| 06/04/2008 | CN101190251A Rhodiola rosea chewable tablets and preparation method and application thereof |
| 06/04/2008 | CN101190250A Chewable tablets for preventing and controlling high-altitude disease and preparation method thereof |
| 06/04/2008 | CN101190249A Composition for preventing and controlling high-altitude disease and preparation method thereof |
| 06/04/2008 | CN101189997A Notoginseng flower brain tonic tea |
| 06/04/2008 | CN100391972C Corticotropin releasing factor receptor 2 agonists |
| 06/04/2008 | CN100391967C Hepatitis C tripeptide inhibitors |
| 06/04/2008 | CN100391958C Chemical compounds |
| 06/04/2008 | CN100391957C Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridyl-n-2-hydroxycarbonylethyl)-amide, preparation method thereof and use as medicine preparation |
| 06/04/2008 | CN100391953C Medicinal use and extraction of cis-ligusticum lactone |
| 06/04/2008 | CN100391942C Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing same and their use in medicaments |
| 06/04/2008 | CN100391534C Modulation of smooth muscle cell proliferation |
| 06/04/2008 | CN100391486C Application of red sage root in preparing medicine for treating aspirin resistance blood vessel disease |
| 06/04/2008 | CN100391477C Tortoise plastron extract for promoting growth of marrow mesenchyme stem cell and its preparing method and applciation |
| 06/04/2008 | CN100391462C Enhanced drug delivery in transdermal systems |
| 06/04/2008 | CN100391453C Cremaster ketone preparation |
| 06/04/2008 | CN100391350C Method for preparing yin-nourishing health-preserving yoghourt with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian solomonsea |
| 06/03/2008 | US7381807 Of given nucleotide sequence; encapsulated in slow release delivery vehicle; includes viral or bacterial antigen; increases cell proliferation, differentiation, cytokine and antibody production for lymphocytes |
| 06/03/2008 | US7381790 Copolymers for suppression of autoimmune diseases, and methods of use |
| 06/03/2008 | US7381746 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative |
| 06/03/2008 | US7381739 Antiserotonine agents; central nervous system disorders; Alzheimer's disease; Parkinson's disease; Huntington's disease; sleep disorders |
| 06/03/2008 | US7381733 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases |
| 06/03/2008 | US7381419 Medical composition kit for treating lesioned abnormal tissue |
| 06/03/2008 | US7381406 Probiotic lactobacillus strains for pets |
| 06/03/2008 | CA2467964C Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 06/03/2008 | CA2401711C Cyclic amide derivatives |
| 06/03/2008 | CA2368186C Use of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 06/03/2008 | CA2339628C Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome |
| 06/03/2008 | CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/03/2008 | CA2305760C Inhibitors of nucleoside metabolism |
| 06/03/2008 | CA2285552C Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |
| 06/03/2008 | CA2279846C Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 06/03/2008 | CA2203237C Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 06/03/2008 | CA2195528C Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 06/03/2008 | CA2160016C Method of forming oligonucleotides |
| 05/29/2008 | WO2008063842A2 Methods of treating neuropathic pain with agonists of ppar-gamma |
| 05/29/2008 | WO2008063424A2 Methods of promoting cardiac repair using growth factors fused to heparin binding sequences |
| 05/29/2008 | WO2008063356A2 Suture-specific coatings for modulated release of biocative agents |
| 05/29/2008 | WO2008063346A2 IL-14α RNA INHIBITORS AND ANTIBODIES TO IL-14α FOR TREATMENT OF AUTOIMMUNE DISEASES AND LYMPHOMAS |
| 05/29/2008 | WO2008062861A1 Extract powder of indigo-containing plant, method for production thereof, and use thereof |
| 05/29/2008 | WO2008062830A1 Spiroquinone compound and pharmaceutical composition |
| 05/29/2008 | WO2008062740A1 Nitrogenated fused ring compound and use thereof |
| 05/29/2008 | WO2008062739A1 Pyrazoles and use thereof as drugs |
| 05/29/2008 | WO2008062559A1 Dietary supplement, anti-fatigue agent or physical endurance enhancer, functional food, or cosmetic |
| 05/29/2008 | WO2008061299A1 Method of treating diabetes |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | WO2007130842A3 Combination therapy for diseases involving angiogenesis |
| 05/29/2008 | US20080125479 Use in inhibiting PI-3-kinase activity in mammals; cancer; Acetic acid 4-diallylaminomethylene-6-hydroxy-1- alpha -methoxymeth-yl-10 beta ,13 beta -dimethyl-3,7,17-trioxo-1,3,4,7,10,11 beta , 12,13,14 alpha ,15,16,17-dodecahydro-2-oxa-cyclopenta[ alpha ]phenanthren-11-yl ester |
| 05/29/2008 | US20080125475 Mixed ORL1/mu-agonists for the treatment of pain |
| 05/29/2008 | US20080125472 Use of an inhibitor of the renin-angiotensin system; candesartan, candesartan cilexetil, losartan, valsartan, irbesartan, tasosartan, telmisartan, and eprosartan |
| 05/29/2008 | US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |